Relay Therapeutics to Announce Third Quarter 2023 Financial Results and Corporate Highlights on November 2, 2023
October 26 2023 - 4:05PM
Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision
medicine company transforming the drug discovery process by
combining leading-edge computational and experimental technologies,
will report third quarter 2023 financial results and corporate
highlights after the U.S. financial markets close on Thursday,
November 2, 2023.
About Relay Therapeutics
Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision
medicine company transforming the drug discovery process by
combining leading-edge computational and experimental technologies
with the goal of bringing life-changing therapies to patients. As
the first of a new breed of biotech created at the intersection of
complementary techniques and technologies, Relay Therapeutics aims
to push the boundaries of what’s possible in drug discovery. Its
Dynamo™ platform integrates an array of leading-edge computational
and experimental approaches designed to drug protein targets that
have previously been intractable or inadequately addressed. Relay
Therapeutics’ initial focus is on enhancing small molecule
therapeutic discovery in targeted oncology and genetic disease
indications. For more information, please visit www.relaytx.com or
follow us on Twitter.
Contact:Megan Goulart617-545-5526
mgoulart@relaytx.com
Media:Dan
Budwick1AB973-271-6085dan@1abmedia.com
Relay Therapeutics (NASDAQ:RLAY)
Historical Stock Chart
From Apr 2024 to May 2024
Relay Therapeutics (NASDAQ:RLAY)
Historical Stock Chart
From May 2023 to May 2024